目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
1.3.1 MARKETS COVERED & REGIONAL SEGMENTATION
1.3.2 INCLUSIONS & EXCLUSIONS
1.3.3 YEARS CONSIDERED
1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
2.4 MARKET RANKING ANALYSIS
2.5 STUDY ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.6.2 SCOPE-RELATED LIMITATIONS
2.7 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS
4.1 FLEXIBLE ENDOSCOPES MARKET OVERVIEW
4.2 NORTH AMERICA: FLEXIBLE ENDOSCOPES MARKET, BY END USER
4.3 GEOGRAPHIC SNAPSHOT OF FLEXIBLE ENDOSCOPES MARKET (2024)
4.4 GEOGRAPHIC MIX: FLEXIBLE ENDOSCOPES MARKET, 2025-2030 (USD MILLION)
4.5 FLEXIBLE ENDOSCOPES MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS, 2025 VS. 2030 (USD MILLION)

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Rising requirement for endoscopy to diagnose and treat target diseases
5.2.1.2 Increasing preference for minimally invasive surgeries
5.2.1.3 Rising incidence of inflammatory bowel disease and colorectal cancer
5.2.2 RESTRAINTS
5.2.2.1 High overhead costs of endoscopy procedures with limited reimbursement in emerging economies
5.2.2.2 Increased risk of getting viral infections during endoscopic procedures
5.2.3 OPPORTUNITIES
5.2.3.1 Rapidly developing healthcare sector in emerging economies
5.2.4 CHALLENGES
5.2.4.1 Increasing number of product recalls
5.2.4.2 Lack of proper sterilization and reprocessing
5.3 TECHNOLOGY ANALYSIS
5.3.1 KEY TECHNOLOGIES
5.3.1.1 Imaging systems
5.3.2 COMPLEMENTARY TECHNOLOGIES
5.3.2.1 Artificial Intelligence (AI) and Image Processing
5.3.3 ADJACENT TECHNOLOGIES
5.3.3.1 Robotic-assisted Endoscopy
5.4 INDUSTRY TRENDS
5.4.1 INCREASING SHIFT TOWARD ADVANCED, VALUE-BASED TECHNOLOGIES
5.4.2 TECHNOLOGICAL ADVANCEMENTS IN ENDOSCOPES
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 SUPPLY CHAIN ANALYSIS
5.8 TRADE ANALYSIS
5.8.1 IMPORT DATA FOR HS CODE 9018
5.8.2 EXPORT DATA FOR HS CODE 9018
5.9 PORTER'S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF BUYERS
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS AND BUYING CRITERIA
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.10.2 KEY BUYING CRITERIA
5.11 REGULATORY LANDSCAPE
5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11.2 REGULATORY ANALYSIS
5.11.2.1 North America
5.11.2.1.1 US
5.11.2.1.2 Canada
5.11.2.2 Europe
5.11.2.3 Asia Pacific
5.11.2.3.1 Japan
5.11.2.3.2 China
5.11.2.3.3 India
5.11.2.4 Latin America
5.11.2.5 Middle East & Africa and GCC Countries
5.12 PATENT ANALYSIS
5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.13 PRICING ANALYSIS
5.13.1 AVERAGE PRICING TREND OF FLEXIBLE ENDOSCOPES BY KEY PLAYER
5.13.2 AVERAGE PRICING TREND OF FLEXIBLE ENDOSCOPES, BY REGION
5.14 KEY CONFERENCES AND EVENTS, 2024-2025
5.15 ADJACENT MARKET ANALYSIS
5.15.1 ENDOSCOPY EQUIPMENT MARKET
5.16 UNMET NEEDS/END-USER EXPECTATIONS
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI ON FLEXIBLE ENDOSCOPES MARKET
5.20 IMPACT OF 2025 US TARIFFS-FLEXIBLE ENDOSCOPES MARKET
5.20.1 INTRODUCTION
5.20.2 KEY TARIFF RATES
5.20.3 PRICE IMPACT ANALYSIS
5.20.4 IMPACT ON COUNTRIES/REGIONS
5.20.4.1 North America
5.20.4.2 Europe
5.20.4.3 Asia Pacific
5.20.5 IMPACT ON END-USE INDUSTRIES

6 FLEXIBLE ENDOSCOPES MARKET, BY TYPE
6.1 INTRODUCTION
6.2 UPPER GI ENDOSCOPES
6.2.1 UPPER GI VIDEOCOPES
6.2.1.1 Easy biopsy of tissues in upper GI tract to support segment growth
6.2.2 UPPER GI FIBERSCOPES
6.2.2.1 Effective treatment of bleeding ulcers and removal of objects stuck in intestine to propel segment growth
6.3 COLONOSCOPES
6.3.1 VIDEO COLONOSCOPES
6.3.1.1 Effective determination of gastrointestinal abnormalities to drive segment
6.3.2 FIBER COLONOSCOPES
6.3.2.1 Easy visual examination of large intestine and rectum to support segment growth
6.4 BRONCHOSCOPES
6.4.1 VIDEO BRONCHOSCOPES
6.4.1.1 Effective examination of abnormalities in airways to propel segment growth
6.4.2 FIBER BRONCHOSCOPES
6.4.2.1 Effective examination of bronchi for diagnostic and therapeutic purposes to aid market growth
6.5 SIGMOIDOSCOPES
6.5.1 VIDEO SIGMOIDOSCOPES
6.5.1.1 Easy viewing of internal organ images on monitor to drive segment growth
6.5.2 FIBER SIGMOIDOSCOPES
6.5.2.1 Increasing focus on medical examination of the large intestine to boost segment growth
6.6 LARYNGOSCOPES
6.6.1 VIDEO LARYNGOSCOPES
6.6.1.1 Effectiveness of endotracheal intubation with general anesthesia to aid segment growth
6.6.2 FIBER LARYNGOSCOPES
6.6.2.1 Easy detection of voice problems and ear and throat infections to drive segment
6.7 PHARYNGOSCOPES
6.7.1 VIDEO PHARYNGOSCOPES
6.7.1.1 Effective throat examination using five-inch hollow tube to drive segment
6.7.2 FIBER PHARYNGOSCOPES
6.7.2.1 Easy viewing of the esophagus and trachea through camera-mounted endoscopes to aid segment growth
6.8 DUODENOSCOPES
6.8.1 VIDEO DUODENOSCOPES
6.8.1.1 Better inspection of digestive tract anatomy to support market growth
6.8.2 FIBER DUODENOSCOPES
6.8.2.1 Increasing focus on better diagnosis and treatment of gastrointestinal disorders to drive segment
6.9 NASOPHARYNGOSCOPES
6.9.1 VIDEO NASOPHARYNGOSCOPES
6.9.1.1 Easy detection of blockages in upper airways to support segment growth
6.9.2 FIBER NASOPHARYNGOSCOPES
6.9.2.1 Better diagnosis of deviated septum and nasal polyps to propel segment growth
6.10 RHINOSCOPES
6.10.1 VIDEO RHINOSCOPES
6.10.1.1 Easy viewing of nasal cavity through video and image transmission to augment segment growth
6.10.2 FIBER RHINOSCOPES
6.10.2.1 Rising focus on diagnosis of inflammation, foreign bodies, tumors, and fungal infections to drive segment
6.11 OTHER FLEXIBLE ENDOSCOPES
6.11.1 OTHER VIDEO ENDOSCOPES
6.11.2 OTHER FIBER ENDOSCOPES

7 FLEXIBLE ENDOSCOPES MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 GASTROINTESTINAL ENDOSCOPY
7.2.1 INCREASING INCIDENCE OF COLORECTAL CANCER IN YOUNGER ADULTS TO PROPEL MARKET GROWTH
7.3 BRONCHOSCOPY
7.3.1 RISING NUMBER OF LUNG CANCER CASES TO AID MARKET GROWTH
7.4 ENT ENDOSCOPY
7.4.1 INCREASING NUMBER OF PATIENTS WITH EAR AND THROAT INFECTIONS TO BOOST MARKET GROWTH
7.5 UROLOGY ENDOSCOPY
7.5.1 INCREASING RISK OF DEVELOPING BLADDER CANCER TO SUPPORT MARKET GROWTH
7.6 OBSTETRICS/GYNECOLOGICAL ENDOSCOPY
7.6.1 INCREASING PREVALENCE OF CERVICAL CANCER TO DRIVE SEGMENTAL GROWTH
7.7 OTHER APPLICATIONS

8 FLEXIBLE ENDOSCOPES MARKET, BY END USER
8.1 INTRODUCTION
8.2 HOSPITALS
8.2.1 AVAILABILITY OF SKILLED PROFESSIONALS AND TECHNOLOGICALLY DEVELOPED SURGICAL FACILITIES TO DRIVE GROWTH
8.3 AMBULATORY SURGERY CENTERS
8.3.1 GROWING PATIENT PREFERENCE FOR QUICKER DISCHARGE AND LOWER COSTS BOOSTS DEMAND FOR AMBULATORY CARE
8.4 CLINICS
8.4.1 ACCESSIBLE, COST-EFFECTIVE, AND SPECIALIZED DIAGNOSTIC AND THERAPEUTIC PROCEDURES TO DRIVE GROWTH
8.5 OTHER END USERS

9 FLEXIBLE ENDOSCOPES MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
9.2.2 US
9.2.2.1 US to dominate North American market during forecast period
9.2.3 CANADA
9.2.3.1 Growing cancer and IBD prevalence, advanced healthcare access, and supportive reimbursement policies to drive market
9.3 EUROPE
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
9.3.2 GERMANY
9.3.2.1 Germany dominated European flexible endoscopes market in 2024
9.3.3 UK
9.3.3.1 Aging population, high cancer prevalence, and strong healthcare infrastructure stimulating market growth
9.3.4 FRANCE
9.3.4.1 Rising health expenditure and high prevalence of cancer to stimulate market growth
9.3.5 ITALY
9.3.5.1 Aging population and rising prevalence of chronic diseases are boosting adoption
9.3.6 SPAIN
9.3.6.1 Rising aging population to drive market growth
9.3.7 REST OF EUROPE
9.4 ASIA PACIFIC
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
9.4.2 CHINA
9.4.2.1 China to account for largest market share in Asia Pacific
9.4.3 INDIA
9.4.3.1 India's large aging population to drive market growth
9.4.4 JAPAN
9.4.4.1 Aging population and cancer prevalence to drive demand for endoscopy procedures in Japan
9.4.5 SOUTH KOREA
9.4.5.1 High aging population, advanced healthcare infrastructure, and technological adoption to drive market growth
9.4.6 AUSTRALIA
9.4.6.1 High cancer incidence, advanced healthcare infrastructure, and widespread adoption of screening programs fuel market expansion
9.4.7 REST OF ASIA PACIFIC
9.5 LATIN AMERICA
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
9.5.2 BRAZIL
9.5.2.1 Brazil accounted for largest share of LATAM market in 2024
9.5.3 MEXICO
9.5.3.1 Expanding healthcare infrastructure and increasing adoption of screening programs to drive Mexico's market
9.5.4 REST OF LATIN AMERICA
9.6 MIDDLE EAST & AFRICA
9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
9.6.2 GCC COUNTRIES
9.6.2.1 Increasing healthcare investments, hospital expansions, and adoption of advanced medical technologies to drive market growth
9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN FLEXIBLE ENDOSCOPES MARKET
10.3 REVENUE ANALYSIS, 2022-2024
10.4 MARKET SHARE ANALYSIS, 2024
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
10.5.5.1 Company footprint
10.5.5.2 Region footprint
10.5.5.3 Type footprint
10.5.5.4 Application footprint
10.5.5.5 End-user footprint
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
10.6.5.1 Detailed list of key startups/SMEs
10.6.5.2 Competitive benchmarking of key startups/SMEs
10.7 COMPANY VALUATION & FINANCIAL METRICS
10.7.1 FINANCIAL METRICS
10.7.2 COMPANY VALUATION
10.8 BRAND/PRODUCT COMPARISON
10.9 COMPETITIVE SCENARIO
10.9.1 PRODUCT LAUNCHES & APPROVALS
10.9.2 DEALS

11 COMPANY PROFILES
11.1 KEY PLAYERS
11.1.1 OLYMPUS CORPORATION
11.1.1.1 Business overview
11.1.1.2 Products offered
11.1.1.3 Recent developments
11.1.1.3.1 Product launches & approvals
11.1.1.3.2 Deals
11.1.1.4 MnM view
11.1.1.4.1 Right to win
11.1.1.4.2 Strategic choices
11.1.1.4.3 Weaknesses & competitive threats
11.1.2 KARL STORZ SE & CO. KG
11.1.2.1 Business overview
11.1.2.2 Products offered
11.1.2.3 Recent developments
11.1.2.3.1 Deals
11.1.2.4 MnM view
11.1.2.4.1 Right to win
11.1.2.4.2 Strategic choices
11.1.2.4.3 Weaknesses & competitive threats
11.1.3 BOSTON SCIENTIFIC CORPORATION
11.1.3.1 Business overview
11.1.3.2 Products offered
11.1.3.3 Recent developments
11.1.3.3.1 Product approvals
11.1.3.3.2 Deals
11.1.3.4 MnM view
11.1.3.4.1 Right to win
11.1.3.4.2 Strategic choices
11.1.3.4.3 Weaknesses & competitive threats
11.1.4 FUJIFILM CORPORATION
11.1.4.1 Business overview
11.1.4.2 Products offered
11.1.4.3 MnM view
11.1.4.3.1 Right to win
11.1.4.3.2 Strategic choices
11.1.4.3.3 Weaknesses & competitive threats
11.1.5 HOYA CORPORATION
11.1.5.1 Business overview
11.1.5.2 Products offered
11.1.5.3 Recent developments
11.1.5.3.1 Product approvals
11.1.5.3.2 Deals
11.1.5.4 MnM view
11.1.5.4.1 Right to win
11.1.5.4.2 Strategic choices
11.1.5.4.3 Weaknesses & competitive threats
11.1.6 NIPRO
11.1.6.1 Business overview
11.1.6.2 Products offered
11.1.7 STERIS
11.1.7.1 Business overview
11.1.7.2 Products offered
11.1.8 ENDOMED SYSTEMS GMBH
11.1.8.1 Business overview
11.1.8.2 Products offered
11.1.9 RICHARD WOLF GMBH
11.1.9.1 Business overview
11.1.9.2 Products offered
11.1.10 AMBU A/S
11.1.10.1 Business overview
11.1.10.2 Products offered
11.1.10.3 Recent developments
11.1.10.3.1 Product launches & approvals
11.1.10.3.2 Expansions
11.2 OTHER PLAYERS
11.2.1 HUGER MEDICAL INSTRUMENT CO., LTD
11.2.2 SONOSCAPE MEDICAL CORP.
11.2.3 ATMOS MEDIZINTECHNIK GMBH & CO. KG
11.2.4 LABORIE
11.2.5 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.
11.2.6 OTU MEDICAL
11.2.7 ZHUHAI PUSEN MEDICAL TECHNOLOGY CO., LTD.
11.2.8 UROVIU CORPORATION
11.2.9 VERATHON INC.
11.2.10 GI-VIEW
11.2.11 OTTOMED (MITRA INDUSTRIES PRIVATE LIMITED)
11.2.12 GUANGZHOU REDPINE MEDICAL EQUIPMENT CO., LTD
11.2.13 TSC LIFE
11.2.14 OUJIAHUA GROUP
11.2.15 FOSHAN JIALIANDA MEDICAL APPARATUS CO., LTD

12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS